CapForce IBD 50 ETF

FFTY

Börsenwert 69,1 Mio. $

LOS ANGELES--(BUSINESS WIRE)---- $BOUT #capforceetf--M2 Financial LLC, in conjunction with Capital-FORCE ETF Trust (“Capital-FORCE”), announced today the successful transition of the CapForce IBD® 50 ETF (ticker: FFTY) and CapForce IBD® Breakout Opportunities ETF (ticker: BOUT) to the Capital-FORCE ETF platform. These two legacy strategies, which are licensed from Investor's Business Daily (“IBD”), have become flagship offerings for Capital-FORCE as it launches a focused family of complementary, dynamic rules-based E.

WHEATON, Ill., April 10, 2026 (GLOBE NEWSWIRE) -- Innovator Capital Management, LLC (“Innovator”) announced today the results of the joint special meeting of shareholders of Innovator IBD® Breakout Opportunities ETF (NYSE Arca: BOUT) and Innovator IBD® 50 ETF (NYSE Arca: FFTY) (each a “Target Fund” and collectively, the “Target Funds”) held of April 10, 2026.

Innovator IBD® 50 ETF is a passively managed ETF tracking the IBD® 50 Index. FFTY is having such a moment this year, beating IVV and QQQ by a substantial margin. For context, 2017 was the only calendar year when this ETF beat IVV. It is worth exercising caution, though, as it is questionable whether outperformance is sustainable.

Cathie Wood's ARK Innovation is having a great year so far versus the S&P 500. But it still can't quite match an even hotter ETF.

Major stock indexes ended mildly lower in the stock market Tuesday, but Google parent Alphabet scored a technical breakout. The post Stock Market Reverses Lower Ahead Of CPI Data; Top-Rated Growth Stocks Pressured Again appeared first on Investor's Business Daily.

US equities, as measured by the S&P 500 Index, have performed strongly so far in 2023.